Premature Ovarian Failure Clinical Trial
Official title:
Ovarian Injection of PRP (Platelet -Rich Plasma) Vs Normal Saline in Premature Ovarian Insufficiency: A Randomized Controlled Trial
60 cases with premature ovarian insufficiency will be randomized to either receive PRP or saline injection in their ovaries. Then follow up by hormonal & ultrasound & clinically to monitor any changes
Status | Not yet recruiting |
Enrollment | 60 |
Est. completion date | December 30, 2021 |
Est. primary completion date | December 1, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 20 Years to 42 Years |
Eligibility | Inclusion Criteria: - PORs who meet at least two of the following three Bologna criteria - AMH: 0.1-1 ng/ml. Exclusion Criteria: - ovarian insufficiency due to gonadal dysgenesis and - - chromosomal abnormalities, - immunoglobulin A deficiency, - the use of anticoagulants, - psychotropic medicaments, - psychiatric disorders, - carcinomas or - a history of chronic pelvic pain. - Women with present infection, - haemoglobin lower than 11 g/L or - platelets lower than 150 x 10?/µL were excluded from the study. |
Country | Name | City | State |
---|---|---|---|
Egypt | Benha University | Banha | Qalyubiya |
Lead Sponsor | Collaborator |
---|---|
Ahmed Saad | Hawaa Fertility Center |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | FSH hormonal changes | The changes in the hormones at day 3 of the menstrual cycle: FSH monitored | 3rd day of the 3rd menstrual cycle after the procedure | |
Primary | vaginal ultrasound monitoring of the ovaries | monitor the number of antral follicles. | 3rd day of the 3rd menstrual cycle after the procedure | |
Primary | clinical follow up | changes in the menstrual cycle by history taking & questionnaire | 3rd day of the 3rd menstrual cycle after the procedure | |
Primary | LH hormonal changes | serum LH at day 3 of the menstrual cycle | 3rd day of the 3rd menstrual cycle after the procedure | |
Primary | E2 hormonal changes | serum E2 at day 3 of the menstrual cycle | 3rd day of the 3rd menstrual cycle after the procedure | |
Primary | AMH hormonal changes | serum AMH | 3rd day of the 3rd menstrual cycle after the procedure |
Status | Clinical Trial | Phase | |
---|---|---|---|
Unknown status |
NCT01853501 -
Effects of ADSC Therapy in Women With POF
|
Phase 4 | |
Completed |
NCT00417066 -
Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor Responders
|
Phase 4 | |
Active, not recruiting |
NCT04675970 -
Long Term Follow up Patients With Premature Ovarian Failure ex Vivo Gene Therapy
|
||
Recruiting |
NCT03480412 -
Second Step Protocol in Poor Ovarian Responder (POR)
|
||
Completed |
NCT02644447 -
Transplantation of HUC-MSCs With Injectable Collagen Scaffold for POF
|
Phase 1/Phase 2 | |
Completed |
NCT03840824 -
Blood Spot Self-administered Test and Assay
|
||
Recruiting |
NCT00119925 -
'SPRING'-Study: "Subfertility Guidelines: Patient Related Implementation in the Netherlands Among Gynaecologists"
|
N/A | |
Recruiting |
NCT06117982 -
The Impact of Granulocyte Colony Stimulating Factor on Premature Ovarian Insufficiency
|
Phase 2 | |
Suspended |
NCT03816852 -
The Safety and Efficiency Study of Mesenchymal Stem Cell (19#iSCLife®-POI) in Premature Ovarian Insufficiency
|
Phase 2 | |
Not yet recruiting |
NCT04390308 -
Is There A Role For Mechanical Stimulation In Ovarian Follicular Activation?
|
||
Completed |
NCT02783937 -
Filgrastim for Premature Ovarian Insufficiency
|
Phase 4 | |
Completed |
NCT00295087 -
X-Chromosome Inactivation Status and Premature Ovarian Failure
|
N/A | |
Completed |
NCT00429494 -
GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients
|
Phase 2 | |
Not yet recruiting |
NCT05522634 -
A Clinical Study of Chinese Herbal Compound TJAOA101 in the Treatment of Premature Ovarian Insufficiency
|
Early Phase 1 | |
Recruiting |
NCT05838157 -
The Effect of HPV Vaccine on Menstrual Cycle in Women of Reproductive Age
|
||
Withdrawn |
NCT01129947 -
The Use of DHEA in Women With Premature Ovarian Failure
|
Phase 0 | |
Completed |
NCT00001275 -
Ovarian Follicle Function in Patients With Primary Ovarian Failure
|
N/A | |
Not yet recruiting |
NCT04306185 -
Ovarian Fragmentation Study (Crespo Medical Team)
|
N/A | |
Recruiting |
NCT02062931 -
Autologous Mesenchymal Stem Cells Transplantation In Women With Premature Ovarian Failure
|
Phase 1/Phase 2 | |
Completed |
NCT02372474 -
"It is a Real" The First Baby Of Autologous Stem Cell Therapy in Premature Ovarian Failure
|
Phase 1/Phase 2 |